The buyback authorization provides downside support but is not a near-term catalyst given discretionary execution. Monitor actual repurchase activity in future filings for signal of management conviction. No earnings or guidance revision accompanies this filing.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 26 $25.05entry
- T+1 · 6mo ago +1.72%α +1.70% · $25.48
- T+5 · 6mo ago +4.59%α +3.51% · $26.20
- T+20 · 5mo ago +7.98%α +9.93% · $27.05
- T+60 · 3mo ago +1.92%α −0.81% · $25.53
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Progyny announced a $200 million share repurchase program, funded from available cash. The program is discretionary with no obligation to repurchase any specific number of shares. This is a capital allocation signal but not a fundamental catalyst.
Key Facts
- Board authorized up to $200 million in common stock repurchases
- Program funded through available cash balances
- Repurchases may be made via open market or Rule 10b5-1 plans
- Program may be suspended or discontinued at any time
- No assurances on number of shares or prices
Financial Impact
$200 million buyback authorization, representing approximately 10.5% of market cap at $1.9B
Risk Factors
- Buyback may not be executed if management deems conditions unfavorable
- Cash used for repurchases reduces balance sheet flexibility
- No fundamental improvement in business operations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001551306-26-000074 |
| Document: 0001551306-26-000074-index-headers.html | 0001551306-26-000074 |
| Document: 0001551306-26-000074-index.html | 0001551306-26-000074 |
| Document: 0001551306-26-000074.txt | 0001551306-26-000074 |
Track record
26 reports on PGNY
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers